drugset / Trial / NCT00731302

Aspirin Resistance in Systemic Lupus Erythematosus (SLE)

NCT00731302

NaSingle-groupOpen-labelOther

Summary

This study examine whether patients with lupus respond to aspirin , and if not, if that is related to inflammation. We examine the ability of aspirin to inhibit the production of thromboxane in patients with lupus and controls and see if aspirin insensitive thromboxane production is inhibited by meloxicam.

Timeline

Start
2005-04
Primary completion
2017-04
Completion
2017-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 81 mg
Subject Meloxicam Small molecule 7.5 mg